Advisory Inquiries
Topic Cluster A • Clinical Hepatology

The Gut-Liver Axis & Metabolic Liver Disease (MASLD)

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects over 30% of adults worldwide. Explore physician-level breakdowns of hepatic de novo lipogenesis, fructose biochemistry, early metabolic biomarkers, and intestinal tight-junction permeability.

Featured Core Guide

Clinical Pillar Guide • 3,200 Words • Medically Reviewed

The Complete Physician's Guide to Reversing MASLD and MASH: Clinical Staging, Biomarkers & Protocol

A definitive clinical guide detailing the progression from simple hepatic steatosis to inflammatory MASH and fibrosis. Learn how to calculate FIB-4 scores, interpret ultrasound steatosis grading, and apply targeted dietary interventions to reverse liver fat accumulation.

AASLD / ACG Evidence Guidelines 3,200 Words Clinical Pillar
Read Complete Guide →
🔬
AASLD & ACG Evidence Benchmark

Features peer-reviewed PubMed citations, diagnostic decision trees, and resmetirom clinical trial breakdowns.

In-Depth Spoke Analyses